Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone vs Prednisolone for Severe CAP
NCT06892197Phase 4Recruiting
- Sponsor
- Copenhagen Respiratory Research
- Start
- Mar 2026
- Primary completion
- Aug 2030
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial in community acquired pneumonia (CAP) comparing Hydrocortisone with Methylprednisolone (2 arms). Primary endpoint: All-cause mortality at 30 days. Started Mar 2026; status: recruiting.
02
Drugs
hydrocortisonemethylprednisolone
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT06892197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06892197.